Molecular and immunohistochemical distinction of equine sarcoid from schwannoma.
Authors: Bogaert L, Heerden M Van, Cock H E V De, Martens A, Chiers K
Journal: Veterinary pathology
Summary
# Editorial Summary: Distinguishing Equine Sarcoids from Schwannomas Equine skin tumours initially diagnosed as schwannomas on routine histology may actually represent an atypical presentation of sarcoid, a finding with significant diagnostic and treatment implications. Bogaert and colleagues re-examined ten such cases using polymerase chain reaction (PCR) testing for bovine papillomavirus (BPV) DNA alongside immunohistochemical staining for cellular markers including S-100 protein, vimentin, laminin, smooth muscle actin, and type IV collagen. All ten tumours tested positive for BPV 1 or 2, and critically, none expressed S-100 protein—a marker that would normally be present in genuine nerve sheath tumours. Instead, the immunohistochemical profile (strong vimentin positivity, moderate laminin reactivity in nine cases, and smooth muscle actin in eight) indicated myofibroblastic origin of the neoplastic cells, definitively identifying these as atypical sarcoids rather than schwannomas. For equine practitioners, this research emphasises that BPV PCR testing combined with S-100 immunohistochemistry should become standard diagnostic protocol for any skin tumour with histological features suggestive of schwannoma or peripheral nerve sheath origin, since misclassification would fundamentally alter treatment strategy—sarcoids typically require different management approaches than truly neurogenic tumours.
Read the full abstract on PubMed
Practical Takeaways
- •Do not rely on routine histology alone for skin tumors resembling schwannomas; many may actually be atypical sarcoids with different treatment implications
- •Request BPV PCR and S-100 immunohistochemistry when pathology reports suggest schwannoma or nerve sheath tumors, as misdiagnosis can lead to inappropriate management strategies
- •Understanding the myofibroblastic nature of these atypical sarcoids may improve targeting of future treatment options beyond current surgical and topical approaches
Key Findings
- •All 10 tumors initially classified as schwannomas were positive for bovine papillomavirus 1 or 2, indicating misdiagnosis
- •Tumors were uniformly negative for S-100 protein, ruling out Schwann cell origin and peripheral nerve sheath tumor diagnosis
- •Immunohistochemical profile (vimentin+, laminin+, SMA+) indicates myofibroblastic origin consistent with atypical equine sarcoid
- •PCR for BPV and S-100 immunohistochemistry are recommended diagnostic tools to differentiate sarcoid from peripheral nerve sheath tumors